METRONOMICS @ MUMBAI 2016

5th BIENNIAL INTERNATIONAL METRONOMIC &
ANTI-ANGIOGENIC MEETING

6th / 7th / 8th MAY, 2016
R.R. Choksi Auditorium, Tata Memorial Hospital, Parel; Mumbai. INDIA

R.R. Choksi Auditorium
Tata Memorial Hospital.

6th / 7th / 8th
MAY, 2016

11 international speakers
The best specialists

300 seats
Hurry up, register!

Overview

5th Biennial "International Metronomic & Anti-Angiogenic Meeting" to be organized from 6th to 8th May 2016. This meeting is being organized by Dept. Of Medical Oncology of TMH as part of the 75th year celebrations of Tata Memorial Centre under the aegis of MGHI, ICON, and ISMPO.

Metronomic Rescheduling of Anticancer Treatment (MSAT)

Even after waging the "war against cancer” for years, most of the advanced cancers are still not curable. Metronomic Rescheduling of Anticancer Treatment (MSAT) has now grown beyond the anticipated scope of anti-angiogenic chemotherapy, with accumulating evidence demonstrating that these treatments may also act by stimulating an antitumor immune response and could ultimately lead to re-induction of tumor dormancy.

Defining
metronomic

Rajabai Clock Tower, a heritage structure of Mumbai that represents Mumbai University, was completed in 1878 through the philanthropy of Mr. Premchand Roychand & is a symbol of both higher education & philanthropy. Also, it chimes a tune every 15 minutes and thus is an apt representation of the definition of “metronomic” which means “unvaryingly regular in rhythm".

11

International Speakers

The best experts will perform for you

159

Hours

The most awaited week-end

20

Technologies

The leading sectors of the Medical

3

Auditoriums

For a comfortable placement

Schedule

Metronomic Scheduling The Next Generation of Multi-Target Therapy

Day -1: Workshop on Clinical Trial Designing & Translational Research for Metronomic Studies

Sandra Doe

Dr Arun C, Dr Mounika, Dr Anant R, Dr Ashay Karpe, Dr Bhavesh Poladia, Dr Deepan M.

Sandra Doe

Dr. B K Smruti, Mumbai; Dr. Manoj Mahimkar, Mumbai; Dr Rita Mulherkar, Mumbai.

John Doe

WHY METRONOMICS?

Pharmacokinetics of low doses : Dr. Vikram Gota, Mumbai

Repositioning of drugs in oncology : The ReDo Project: Dr. Pan Pantziarka, Belgium

Key note lecture : Next - generation drug repositioning : using high-throughput screening technology to improve cancer treatment : Dr. Eddy Pasquier, France

John Doe

Question and answer session

Tea Break

Michael Doe

Dr. Asha Kapadia - Mumbai, Dr. Nicolas Andre - France, Dr. Rakesh Jalali - Mumbai

John Doe

DESIGN OF METRONOMIC STUDIES:

Single Arm studies in metronomic therapy : Dr. Aparna Parikh, Mumbai

Randomized Phase 2 studies in metronomic therapy : Dr. Sudeep Gupta, Mumbai

Randomized Phase 3 studies in metronomic therapy: Dr. Kumar Prabhash, Mumbai

Response assement in metronomic therapy
Radiologist View: Dr. Abhishek Mahajan, Mumbai
Nuclear Medicine view : Dr Nilendu Purandare, Mumbai

LUNCH

John Doe

Dr Lisa Hutchinson - UK, Dr Urmila Thatte - Mumbai, Dr. Robert Kerbel - Canada.

John Doe

ENDPOINT SELECTION IN METRONOMIC TRIALS:

Appropriate clinical end point selection for metronomic studies : Dr. Atanu Bhattacharjee - Thalassary

Selection of Translational end points for metronomic studies : Dr. Shona Nag - Pune

Tumor Immunity related marker selection and methodologies for metronomic studies: Dr. Shubhada Chiplunkar, Navi Mumbai

Efficacy V/s. Toxicity endpoint selection for metronomic studies : Dr. Sadhana K - Navi Mumbai

John Doe

Question and answer session

Michael Doe

Dr. SH Advani - Mumbai, Dr. Pratamesh Pai - Mumbai, Dr. Amol Dongre - Nagpur

John Doe

MATHEMATICS & BIOLOGY IN METRONONIC THERAPIES:

Mathematical Modelling of Chemotherapy Scheduling: Dr. Sébastien Benzekry - France

Systematic analysis of host and tumor effects to metronomic chemotherapy regimen : Dr. Yuval Shaked, Israel

John Doe

Question and answer session

Tea Break

Michael Doe

Dr. Jayant Gawande - Pune; Dr. Pankaj Shah - Ahmadabad; Dr.Prashant - Chennai.

John Doe

Debate: Tumor shrinkage (objective response) or clinical benefit rate : Which is the appropriate efficacy endpoint for metronomic therapy?

For Tumor shrinkage : Dr Amish Vora, Delhi (10 min)
For Clinical benefit rate : Dr Randeep Singh, Delhi (10 min)
Retrieval 5 min each

John Doe

Panel Discussion: Survey of practice, perception and promise in metronomic therapy and generation of a consensus statement

Moderators: Dr Purvish Parikh, Mumbai & Dr Vanita Noronha, Mumbai

Panelists: Dr GS Bhattacharyya, Kolkatta; Dr Sudeep Gupta, Mumbai; Dr Kumar Prabhash, Mumbai; Dr Satheesan B, Thallasery; Dr Raman Govindarajan, Mumbai; Dr Partha Roy, Gauhati; Dr Nishita Shetty, Mangalore; Dr Gautam Goyal , Mumbai ; Dr Hari Menon, Mumbai; Dr Avinash Pandey, Hyderabad; Dr Padmaj Kulkarni, Pune; Dr Bharat Bhosale, Mumbai; Dr Amit Dutt, Mumbai.

Register right now!

Partners and Sponsors

Contact

  • R.R. Choksi Auditorium,
    Tata Memorial Hospital,
    Parel, Mumbai. India.
  • event@metronomicsmumbai.com
  • Dr. Shripad Banavali - 9820074514
  • Dr. Vijay Patil - 9869382266

Copyrights © Metronomics Mumbai 2016 | Complete Web & IT Solutions by NWDCo